Home » Topics » BioWorld Science

BioWorld Science
RSS

Potent, orally bioavailable FTase inhibitors discovered at Aventis

Aug. 28, 2001

Aventis highlights pipeline progress for first half of 2001

Aug. 28, 2001

Invitrogen to market lentiviral vectors from Cell Genesys

Aug. 28, 2001

Enbrel shows positive results in phase II clinical study of psoriasis

Aug. 28, 2001

Two centers added to 12-week study of Neotrofin in spinal cord injury

Aug. 28, 2001

Helivax demonstrates safety, immunogenicity in phase Ib trial

Aug. 28, 2001

Pharmacopeia and Eos Biotechnology agree to merge

Aug. 28, 2001

CA4P development program continues as planned

Aug. 28, 2001

Nycomed Amersham Imaging and Affitech expand human antibody agreement

Aug. 28, 2001

CV Therapeutics commences phase II clinical trial of CVT-3146

Aug. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...